Cortrosyn

Cortrosyn is a brand name of cosyntropin, approved by the FDA in the following formulation(s):

CORTROSYN (cosyntropin - injectable; injection)

• 
  Manufacturer: AMPHASTAR PHARMS INC
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 0.25MG/VIAL ^[RLD][AP]

Has a generic version of Cortrosyn been approved?

Yes. The following products are equivalent to Cortrosyn:

cosyntropin injectable; injection

• 
  Manufacturer: BIONICHE PHARMA
  
  Approval date: December 17, 2009
  
  Strength(s): 0.25MG/VIAL ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cortrosyn. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Cortrosyn.

See also...

• Cortrosyn Consumer Information (Wolters Kluwer)
• Cosyntropin Consumer Information (Wolters Kluwer)